Article thumbnail

Spread of a highly mucoid Streptococcus pyogenes emm3/ST15 clone

By Esther Tamayo, Milagrosa Montes, Guadalupe García-Medina, José M García-Arenzana and Emilio Pérez-Trallero
Topics: Research Article
Publisher: BioMed Central
OAI identifier:
Provided by: PubMed Central

To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.

Suggested articles


  1. (2007). Active Bacterial Core Surveillance Team: The epidemiology of invasive group A streptococcal infection and potential vaccine implications: United States, 2000-2004. Clin Infect Dis
  2. (2001). Albertí S: [Invassive infections caused by Group A streptococci: clinical characteristics and microbiological analyses in 31 cases]. Enferm Infecc Microbiol Clin
  3. (1995). de Rijn I: Hyaluronic acid synthesis operon (has) expression in group A streptococci.
  4. (2007). EL: Group A streptococcal isolates temporally associated with acute rheumatic fever in Hawaii: differences from the continental United States. Clin Infect Dis
  5. (2000). Group A streptococcal infections in injection drug users in Barcelona, Spain: epidemiologic, clinical, and microbiologic analysis of 3 clusters of cases from
  6. (2004). HR: Temporal association of the appearance of mucoid strains of Streptococcus pyogenes with a continuing high incidence of rheumatic fever in Utah. Pediatrics
  7. (2008). JB: The importance of the group a streptococcus capsule in the pathogenesis of human infections: a historical perspective. Clin Infect Dis
  8. (2009). Laboratory Standards Institute: Performance standards for antimicrobial susceptibility testing; 19th informational suplement. CLSI documents M100-S19
  9. (1999). Phenotypic and genotypic characterization of Streptococcus pyogenes isolates displaying the MLSB phenotype of Tamayo et al.
  10. (2004). Rheumatic fever. Orphanet encyclopedia
  11. (2009). StrepEURO Study Group, Jasir A: Clinical and microbiological characteristics of severe Streptococcus pyogenes disease in Europe.
  12. (1991). TJ: Hyaluronic acid capsule is a virulence factor for mucoid group A streptococci.